News Listing

Press Release / Medienmitteilung Universität Basel 
For his achievements in cancer research, the cell biologist Prof. Michael N. Hall, from the Biozentrum of the University of Basel, has been awarded the Charles Rodolphe Brupbacher Prize 2019. The Prize Ceremony will take place on January 31, 2019,...

The NCCR RNA & Disease would like to congratulate Lukas Jeker (University of Basel) and Martin Jinek (University of Zurich) on being awarded ERC Consolidator Grants. The project of Lukas Jeker with the acronym "TALE" is on "Therapeutic Allele Engineering: A novel technology for cell therapy", while...

The Zeb1/miR200 axis has been implicated in the regulation of a crucial transition in cancer. However, in vivo studies of the relevance of this axis have been lacking. The lab of NCCR RNA & Disease principal investigator Markus Stoffel now reports their in vivo findings regarding this axis in a...

To answer this question the lab of NCCR RNA & Disease principal investigator Mariusz Nowacki joined forces with researchers from two biotechnology companies and applied different technological approaches. Their findings were published in a PLoS One article entitled "Determination of the presence of...

The ninth edition of the NCCR RNA & Disease Newsletter -The Messenger has been published.

Click here to read The Messenger

We would like to welcome Jacob Corn as a new associate member of the NCCR RNA & Disease.